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ScienceDirectHuman accelerated regions (HARs) are DNA sequences that
changed very little throughout mammalian evolution, but then
experienced a burst of changes in humans since divergence
from chimpanzees. This unexpected evolutionary signature is
suggestive of deeply conserved function that was lost or
changed on the human lineage. Since their discovery, the
actual roles of HARs in human evolution have remained
somewhat elusive, due to their being almost exclusively non-
coding sequences with no annotation. Ongoing research is
beginning to crack this problem by leveraging new genome
sequences, functional genomics data, computational
approaches, and genetic assays to reveal that many HARs are
developmental gene regulatory elements and RNA genes, most
of which evolved their uniquely human mutations through
positive selection before divergence of archaic hominins and
diversification of modern humans.
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Introduction
Humans are in many ways typical primates, but our
species does differ from its evolutionary cousins in several
ways, ranging from unique behaviors and social structures
to morphological changes associated with upright walk-
ing, metabolic differences necessitated by a diet high in
starch, lactose, and meat, and a distinctive disease profile
[1–3]. The sequencing of mammalian genomes revolu-
tionized such comparisons by enabling searches for the
genetic differences between species [4,5,6], as well as
studies aimed at linking these sequence changes towww.sciencedirect.com divergent molecular or organism traits [7,8,9]. These
comparative genomic studies differ in their methodologi-
cal details and the data sets employed, but they have a
common goal: to identify Human Accelerated Regions
(HARs), DNA sequences with dramatically increased
substitution rates in the human lineage. This lineage
has generally been taken as the 6 million years since
humans diverged from our closest living relatives, the
chimpanzees and bonobos, although tests for accelerated
evolution have also been used to study older events [4]
and events in other lineages [10], as well as HARs that
arose after divergence from archaic hominids [11,12,13].
In this paper, we review the discovery of HARs, discuss
the evolutionary forces that may have shaped these fast-
evolving sequences, and summarize what is known about
their functions.
Scanning multiple sequence alignments for
accelerated regions
Detecting acceleration on a particular lineage involves a
statistical test comparing the DNA substitution rate
observed on that lineage with the rate expected given
the rest of the tree (Box 1). This test is explicitly different
from tests for positive selection, which compare observed
substitution rates to those expected under a neutral model
[14–16]. Rather, it is looking for a lineage-specific increase
in the substitution rate compared to a sister lineage or the
rest of the tree and will therefore produce a high score
whether the lineage experiences a shift to positive selec-
tion or a relaxation of negative selection (Figure 1). In the
case of the human lineage, where functional elements may
have zero expected substitutions, acceleration tests can
reach genome-wide significance even when there are
only a few human-specific substitutions (i.e. not many
more than expected under a neutral model). Hence, tests
for acceleration can be more powerful than those for
selection. Nonetheless, many accelerated regions do
show signatures of positive selection (see below).
Typically, one is interested in detecting accelerated
evolution in functional elements, such as promoters,
enhancers, exons, or splice sites. However, since much
of the non-coding genome remains to be fully annotated,
the usual approach has been to use evolutionary conser-
vation as a proxy for function and perform the test on
conserved elements. One source for these is the phast-
Cons program [17], which uses a phylogenetic hidden
Markov model. The open-source software packageCurrent Opinion in Genetics & Development 2014, 29:15–21
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Box 1 Statistical tests for accelerated regions
The goal of a test for accelerated evolution is to determine if the rate
of DNA substitutions is faster than expected in a lineage of interest.
This lineage can be a single branch (e.g. human since divergence
from chimp), a clade (e.g. great apes), or an extinct species (e.g.
ancestor of all primates). A variety of tests have been proposed,
including ones that estimate substitutions via models of molecular
evolution [23,54] and ones that compare parsimony-inferred counts
of substitutions [21,22]. Some tests make use of the phylogenetic
relationships between species to derive expected numbers of
substitutions in the lineage of interest, while others directly compare
sister species. Regardless of these distinctions, the idea is to
determine whether the data in a multiple sequence alignment is more
consistent with lineage-specific acceleration versus the expected
rate of substitutions. This cross-species approach is related to, but
distinct from, methods that employ polymorphism data to identify
selection within a species [55].
The data used to identify accelerated regions are aligned DNA
sequences from multiple species with a phylogenetic tree, which is
either known a priori or computed from the sequence data. There are
also specialized comparative genomics methods for identifying slow
and fast evolving proteins [16,56] or RNA genes [57], which use
alignments of codons, amino acids, or structured RNA, as well as
methods based on loss and gain of regulatory motifs (Siepel and
Arbiza, in this issue) [58]. These are powerful approaches for
studying specific small subsets of the genome, but DNA-based
methods are needed for unbiased, genome-wide scans.
Whole genomes can in principle be analyzed for lineage-specific
acceleration one base pair (bp) at a time, although this approach has
very low power compared to testing windows 100 bp or larger [54].
To focus on functional windows of the genome, analyses have
typically used evolutionarily conserved elements. Because accel-
eration on the lineage of interest may prevent a region from being
classified as conserved, this lineage should be removed from the
alignment before generating the conserved elements [4]. Accelera-
tion tests can also be applied to neutral regions to detect gain-of-
function events, provided the regions are long enough to have
sufficient power.
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different tests for accelerated evolution via the phyloP
function.
Discovering the fastest-evolving regions of
the human genome
Beginning in 2006, a number of studies applied genome-
wide tests for human acceleration to various sets of
mammal-conserved elements [4,19,20], many of which
excluded protein-coding exons [21–23]. Capra and col-
leagues [9] recently compared these studies and found
that HAR data sets produced without coding filters were
nonetheless comprised of mostly non-coding sites
(96.6%). They also produced a combined list of non-
coding HARs (ncHARs), which we analyze further here
after dropping any that show little support in the most
recent alignments (UCSC hg19 conservation track).
These 2701 ncHARs are short (mean length = 266 base
pairs (bp)), although they are often flanked by other
conserved elements that are not accelerated, suggesting
that the HAR is part of a larger functional element. As
expected, ncHARs have many more substitutions in
human (mean = 1.7 per 100 bp) compared to other mam-
mals, which are highly conserved (chimp mean = 0.2 per
100 bp). Even though a typical ncHAR has only a few
human-specific substitutions, this rate is significantly
faster than other conserved elements [17,24] (phastCons;
http://genome.ucsc.edu; bootstrap P < 0.01, based on 100
mammalian phastCons elements per HAR matched for
length and chromosome) and the background (bootstrap
P < 0.01, based on 100 flanking regions per HAR
matched for length). It is also about three times the
neutral rate, enabling inferences about positive selection
versus loss of constraint in individual HARs (see below).(c)
(f)
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Human population-specific polymorphisms are depleted in HARs. (a)
African population-specific polymorphisms in HARs (arrow) compared to
distributions of flanking regions (red) and phastCons elements (blue). (b)
European population-specific polymorphisms. (c) Asian population-
specific polymorphisms.It is important to note that structural variations, rather
than substitutions, comprise the majority of bases that
differ between human and chimp [5]. Unfortunately,
misaligned or misassembled paralogous regions produce
many false positives in scans for HARs [20], and therefore
most studies filtered out duplicated regions, despite
their importance. However, complementary approaches
have revealed human-specific duplications [25,26] and
deletions [27] of genes and conserved non-coding
elements, as well as an enrichment of HARs in duplicated
loci [22,28]. Recent alignment methods that handle
duplications [29,30] may alleviate the need for paralog
filtering.
Recently evolved and evolving HARs
Genomes from archaic hominins and diverse modern
humans provide information about when along the
human lineage HAR mutations arose. We analyzed
ncHARs for mutations shared with a Neanderthal [11]
and a Denisovan [12] using other primates (100-way
alignments; http://genome.ucsc.edu) to polarize differ-
ences. We estimate that 7.1% of human–chimp differ-
ences in ncHARs occurred after divergence from archaic
hominins and 2.7% are shared. The post-archaic fraction
is similar to that observed in targeted sequencing of
HARs captured from an Iberian Neanderthal fossil
[31]. Compared to chimp–human differences in flanking
regions and phastCons elements, those in ncHARs are
significantly more likely to be pre-archaic (90% show
derived allele only in Neanderthal and Denisovan; both
P < 0.01). Thus, the archaic hominins provide some
evidence for a depletion of accelerated evolution in the
past 1 million years of human evolution compared to
earlier in our lineage.
Next, we analyzed the autosomal ncHAR sequences of 54
unrelated modern humans (Supplemental Table 1) from a
diverse set of populations (http://www.completegen-
omics.com/public-data/69-Genomes/) [32]. As expected,
most human–chimp differences in HARs appear to be
fixed. Nonetheless, many ncHARs are polymorphic, with
polymorphism rates similar to flanking regions but
higher than phastCons elements (P < 0.01). ncHAR poly-
morphisms also tend to be older (11% pre-archaic;
both P < 0.01), with higher derived allele frequency
(mean = 22%; both P < 0.01), and less frequently private
to any major population group (unadmixed European,
Asian, or African) (Figure 2). This signature could poten-
tially result from derived alleles in the reference genome
contributing to the original identification of HARs,
although only 10% of human–chimp differences are
polymorphic, which is only a slight enrichment compared
to flanking regions (P = 0.12) and similar to phastCons
elements (P = 0.16). Alternatively, positive selection,
biased gene conversion (see below), or relaxation of
constraint in HAR regions may have driven the enrich-
ment for older, higher frequency alleles in HARs. Futurewww.sciencedirect.com work is needed to disentangle these possibilities. To
facilitate further analyses, we provide a table of summary
statistics for individual ncHARs (Supplemental Table 2).
Evolutionary forces driving human
accelerated evolution
The primary motivation for identifying HARs was to find
functional elements that experienced positive selection
on the human lineage. Indeed, most HARs have substi-
tution rates significantly higher than genome-wide or
local neutral rates [20,33]. Different studies reportedCurrent Opinion in Genetics & Development 2014, 29:15–21
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Genomic distribution of non-coding HARs. Proportion of ncHARs in each
non-coding annotation category compared to conserved elements and
the whole human genome.variable amounts of population genetic evidence for
recent selection in HAR loci [20,22,34], likely due to
using different sets of HARs and polymorphism data.
These results, coupled with our observation that human–
chimp differences are enriched before divergence from
archaic hominins, suggest that many HARs were created
by positive selection and that the adaptive events are not
preferentially linked to the emergence and dispersal of
modern humans.
However, it has been suggested that HARs might result
from GC-biased gene conversion (gBGC) rather than
positive selection, because they harbor excess weak (A/
T) to strong (G/C) substitutions, especially in the fastest
evolving HARs [20,34–36]. This trend (also seen in fast-
evolving exons [37]) drove development of novel
methods for detecting gBGC and distinguishing it from
other evolutionary forces via comparisons to neutral sub-
stitution rates [33,38,39]. This produced estimates that
the majority of HARs were shaped by positive selection,
with gBGC and loss of constraint each explaining 20%
[33]. HAR2/HACNS1 is an example of a predicted
gBGC event, which may have produced human-specific
enhancer activity through loss of repressor function
[40,41]. HARs created by loss of constraint are other good
candidates for loss-of-function studies. While functional
experiments are needed to confirm putative adaptive and
non-adaptive effects of HAR substitutions, sequence
based analyses have established that a combination of
positive selection and other evolutionary forces likely
contributed to the creation of HARs.
Genomic distribution of HARs
The genomic distribution of ncHARs is not random.
They tend to cluster in particular loci and are significantly
enriched nearby developmental genes, transcription fac-
tors, and genes expressed in the central nervous system
[9,20,42,43,44]. Most are not in the promoters or tran-
scripts of these genes, but instead are found in intergenic
regions (59.1% of bp; based on Gencode annotations [45])
(Figure 3), significantly farther from the nearest transcrip-
tion start site than other conserved elements [9]. We
also analyzed the HARs from studies that did not filter
out coding sequences and found that these are 3.4%
coding, more than the genome (1.1%) but much less than
random subsets of similar numbers of phastCons elements
(14.2–24.3%). Thus, a typical HAR is located together with
several other HARs in a gene desert flanked by one or more
developmental transcription factors.
Experimental exploration of HAR functions
While the genomic distribution of ncHARs is suggestive
of distal regulatory elements, very few ncHARs have
annotated functions. A small fraction encodes non-coding
RNAs (5.1% of bp), including the validated long non-
coding RNA HAR1 [19,46]. On the basis of sequence
features and functional genomics data, a recent studyCurrent Opinion in Genetics & Development 2014, 29:15–21 predicted that at least one third of ncHARs function as
gene regulatory enhancers active in many different
embryonic tissues [9]. Indeed, this study and several
smaller ones have used transient transgenic reporter
assays to test 45 ncHARs for activity at a few typically
studied developmental time points. They found 39
ncHARs that can drive gene expression in zebrafish
and/or mouse embryos [7,8,43,47]. An additional 23
out of 47 tested ncHARs show positive developmental
enhancer activity in the VISTA Enhancer Browser (http://
enhancer.lbl.gov). Cotney et al. [48] further showed that
16 ncHARs, including HAR2, gained an epigenetic mark
of active enhancers in the human lineage. These results
strongly support the hypothesis that many ncHARs func-
tion as enhancers, although the set of tested candidates is
still too small and non-randomly selected for a precise
estimate of the true number of ncHAR enhancers.
Transgenic enhancer assays also enable the activity of a
human ncHAR sequence to be compared to its ortholog
from chimpanzee or other mammals. Of 26 ncHAR
enhancers that have been tested using both human and
non-human primate sequences, seven drive human-
specific expression patterns in mouse embryos at day
11.5. The tissues with differential expression are limb
(HAR2, 2xHAR114), eye (HAR25), forebrain
(2xHAR142, 2xHAR238), and the midbrain–hindbrain
boundary (2xHAR164, 2xHAR170). The functional
implications of these expression differences remain to
be discovered, but it is tempting to speculate that changes
in the development of these tissues could influence
human anatomy and traits such as fine motor skills,
spoken language, and cognition.
Future directions for HAR research
The past few years have seen a shift in HAR research
from sequence based studies to functional validations,
including the discovery of several human-specific enhan-
cers, suggesting that developmental gene regulatorywww.sciencedirect.com
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However, there are still many hurdles to linking genetic
changes to divergent traits. One caveat of using transgenic
mice or fish to assay HAR activity is that the trans
environment is not identical to either human or chim-
panzee. Indeed, trans regulatory factors have played a
significant role in human evolution (Nowick, in this
issue). However, a study that tested orthologous human
and zebrafish enhancers in both zebrafish and mouse
found almost no trans effects [49]. Another problem is
that only a small number of candidate enhancers can be
screened with these relatively costly and time-intensive
techniques. New genomic technologies, such as mas-
sively parallel reporter assays [50,51] and genome editing
[52], are opening the door to high-throughput screens of
many HARs in model systems as well as human and non-
human primate cells. These approaches will enable the
validation and comparative analysis of HARs in more cell
types and a larger range of developmental stages, which is
critical for discovery of HARs with divergent enhancer
activity. They may also lead to ways to easily test non-
enhancer functions, such as insulators and repressors for
which there are currently no straightforward assays.
Without a doubt, we are likely to learn the molecular
functions of many more HARs in the coming decade. But
the critical downstream functional studies needed to link
molecular changes to traits remain low-throughput and
challenging for the foreseeable future. Perhaps as more
humans are sequenced we will be able to study the traits
of individuals with ancestral or mutant versions of HARs
to discover functional effects at the population level. It
will be particularly interesting to discover disease associ-
ations in HARs and to eventually unravel the roles HARs
played in the evolution of human disease.
In conclusion, it is important to remember that accelerated
regions are not a human-specific trait. Overall, we are not a
particularly fast-evolving species. There have been more
sequence changes [5] and potentially more selective
events [53,54] in the chimp lineage than in ours. In fact,
the statistical techniques for identifying accelerated
regions have already been applied to other lineages
[4,10]. The data and methods are already available to
explore patterns of accelerated region evolution across
the mammalian phylogeny. These studies will shed light
on what, if anything, is uniquely human about the genes
and pathways targeted by accelerated evolution in our
species.
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